The Risks and Benefits of Taking a Break From...

Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA and MRD testing. TRANSCRIPT Dr. Monty Pal: Hello, and welcom ...  عرض المزيد

Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers that were presented at the 2026 ASCO Genitourinary Cancers Symposium. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcas ...  عرض المزيد

"Cancer doesn't have to be a death sentence. It can be an awakening to a whole new way of living." - Dr. Nasha Winters Today, I sit down with Dr. Nasha Winters for an eye-opening conversation about revolutionizing cancer care. From her own journey surviving stage 4 ovarian cance ...  عرض المزيد

Today I am speaking with Dr. Leigh Erin Connealy, MD. Dr. Connealy is absolutely amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention.

We discuss cancer ra ...

Can thyroid issues increase your cancer risk—or could they hold the key to preventing it altogether?In this episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson welcomes renowned integrative physician Dr. Leigh Erin Connealy, author of The Cancer Revolution. ...  عرض المزيد

Dr. Rohan Garje shares the updated recommendations for the ASCO guideline on systemic therapy for patients with metastatic castration-resistant prostate cancer. He discusses the systemic therapy options for patients based on prior therapy received in the castration-sensitive and ...  عرض المزيد